Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
2
×
detroit blog main
detroit top stories
drug prices
eli lilly
gilead sciences
immunotherapy
indiana blog main
indiana top stories
life sciences
medicare
national
national blog main
national top stories
new york blog main
new york top stories
novartis
2
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
acquisition
adalimumab (humira)
adaptimmune
aducanumab
aduro biotech
What
price
2
×
airport
annual
apocalypse
approval
beds
bio
biogen’s
biopharmaceutical
celgene
companies
convo
days
drug
earlier
failures
fallout
gone
home
j.p
jpm
littered
nash
new
news
notes
remains
road
roundup
sleep
staggers
strategy
talk
time
vortex
Language
Current search:
novartis
×
price
×
" bristol-myers squibb "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
